Ergoteles LLC Gilead Sciences, Inc. Transaction History

Ergoteles LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$76.01 - $86.7 $11.2 Million - $12.8 Million	-147,331 Reduced 95.4%	7,098 $547,000
Q1 2023 May 10, 2023	BUY	$77.31 - $88.08 $11.9 Million - $13.6 Million	154,429 New	154,429 $12.8 Million
Q2 2022 Aug 12, 2022	SELL	$57.72 - $65.01 $2.24 Million - $2.52 Million	-38,758 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$57.92 - $72.58 $2.24 Million - $2.81 Million	38,758 New	38,758 $2.3 Million

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.